Kisspeptin + oxytocin · KLOW protocol

Hormonal cascade, intentional.

Kisspeptin sits upstream of the entire HPG axis. Oxytocin governs the affiliation and bonding circuitry. Together — the community-defined KLOW protocol — they form a cleanly-targeted intimacy intervention. The reviewing physician determines whether it fits your case.

For couples and individuals investing in long-arc relationship quality.

kisspeptin 10oxytocin

Licensed physicians

8-state coverage

503B compounding pharmacy

FDA-registered, cGMP-compliant

Cold-chain validated

2–8°C door-to-door

Refundable consult

If the physician declines

Alex, 42. Tight portrait, soft expression. Reads as: settled, intentional, post-30s relationship-investing user. REPLACE: ideally a paired-couple aesthetic shot.

First month bundle

$269

Consult + first month’s prescription. Refills $199/mo · about $8.90/day

  • Async consult with a licensed physician
  • Kisspeptin-10 + oxytocin (if appropriate)
  • Cold-chain shipped, pen-ready vials
  • Conduit pen + 30 pen needles
  • Discreet packaging
  • Conduit+ membership for the duration
Start intake

Refundable consult if the physician declines.

Why people pick this

I expected nothing. Four weeks in, both of us noticed. My wife asked what I was doing differently before I told her.

Conduit Care user · Intimacy protocol

G01  /  The science

The mechanism, in plain English.

Kisspeptin-10 is a neuropeptide upstream of GnRH; it drives LH/FSH secretion and downstream sex-steroid production. Oxytocin is the affiliation hormone — bonded-pair behaviors, post-coital warmth, social trust. Half-lives are short; timing relative to the intended window matters.

  • NoteKisspeptin-10 SC drives a measurable LH/FSH rise within 60–90 minutes (Dhillo et al., J Clin Endocrinol Metab 2007)
  • NoteOxytocin SC half-life ~20 minutes; intranasal route extends window for some users
  • NoteKLOW composition varies by community source — Conduit Care defaults to Kisspeptin-10 + oxytocin, physician may adjust
  • NoteNo FDA-approved indication; physician oversight especially relevant
G02  /  Your timeline

What changes, and when.

01 · Week 1–2

Cold-chain shipment with both vials. First dose logged. Timing protocol explained.

02 · Week 4

Most users report subjective changes by this point. Track frequency and quality in the app.

03 · Week 8

Mid-cycle check-in. Physician adjusts dose or timing.

04 · Week 12

Common cycle endpoint. Many continue at maintenance.

G03  /  The difference

Three ways to run intimacy.

Do nothing

Status quo.

  • · No risk, no result
  • · Hope it resolves on its own
  • · No data captured
  • · $0 / month

Self-source

Research-supply gamble.

  • · Unverified source + COA
  • · No physician oversight
  • · Reconstitute yourself
  • · Maybe $100–200 / month

Conduit Care

Pharma-grade.

  • · 503B pharmacy + COA
  • · Physician-supervised
  • · Cold-chain shipped, pen-ready
  • · $199/mo refill

The physician

Licensed in your state.

Your case is reviewed asynchronously by a physician licensed in your state of residence. They evaluate your medical history, current medications, and contraindications against the requested protocol. They approve, decline, or request more information. They are accountable for the prescription.

24-hour median response

The pharmacy

503B compounding.

An FDA-registered 503B outsourcing facility fills your prescription. cGMP-compliant production. Lot-tracked vials. USP <797> sterile compounding standards. Validated 2–8°C cold-chain transit from the fill line to your door.

FDA-registered, cGMP-compliant

G04  /  Questions

Before you start.

How is this different from buying research peptides online?
A licensed physician reviews your medical history and writes a prescription before anything ships. A 503B compounding pharmacy fulfills the prescription — meaning FDA-registered facility, cGMP-compliant production, validated cold-chain transit. Research-supply sites operate without prescription oversight or pharmacy-grade fulfillment. The product, the process, and the accountability are categorically different.
How long does the review take?
Most cases are reviewed within 24 hours. The physician may approve, request more information, or decline based on contraindications. If declined, the consult fee is refunded in full.
Is this telehealth or in-person?
Asynchronous telehealth only. You complete an intake form, upload an ID, the physician reviews on their own schedule. No video visit required. You can complete the entire intake in under five minutes and the physician responds in under 24 hours.
What if I already use insulin syringes and vials?
You can still use Conduit. The Conduit pen accepts the cold-chain reconstituted vials we ship — no draws, no math. If you prefer to keep using syringes, you can buy the pen separately on /shop. The Conduit app tracks doses either way.
What states do you ship to?
Conduit Care is currently live in Texas, Tennessee, Oklahoma, Louisiana, Arizona, Georgia, Florida, and New York. Coverage depends on physician licensure and pharmacy reach. We expand quarterly. If your state isn’t live yet, the waitlist is the fastest way to know when it goes live.
G05  /  What this is not

Not a guarantee.
Not for everyone.

  • · The reviewing physician determines dose, duration, and eligibility based on your intake. They may decline.
  • · Intimacy protocols are not FDA-approved indications for these peptides. Conduit Care operates within compounded- product framework with licensed physician oversight.
  • · Outcomes vary. Conduit doesn’t make therapeutic claims; the platform supports adherence and tracking.
  • · Consult fee is refundable if the physician declines. Prescription cost is not refundable once filled.

Ready

Start your intimacy protocol.

A licensed physician reviews in under 24 hours. Refundable if declined.

Conduit products are sterile fluid transfer devices intended for research applications. Conduit Care is a separate asynchronous telehealth service. Not intended for diagnosis, treatment, or prevention of any disease. The Intimacy protocol is not an FDA-approved indication for these peptides; it is a compounded-product framework under licensed physician oversight.